Lymphoproliferative disease with mixed cryoglobulinemia and hyperviscosity syndrome in an HIV-infected patient: HCV is the only culprit.
暂无分享,去创建一个
F. Castelli | I. Izzo | C. Cattaneo | A. Spinetti | S. Zaltron | S. Casari | S. Odolini | C. Grecchi | P. Zanotti | C. Chirico | E. Festa
[1] S. S. Levinson,et al. Analysis, detection and quantitation of mixed cryoglobulins in HCV infection: brief review and case examples , 2016, Clinical chemistry and laboratory medicine.
[2] R. Bruno,et al. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection. , 2016, Blood.
[3] M. Merli,et al. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma , 2016, World journal of gastroenterology.
[4] E. Herrmann,et al. The anti‐lymphoma activity of antiviral therapy in HCV‐associated B‐cell non‐Hodgkin lymphomas: a meta‐analysis , 2016, Journal of viral hepatitis.
[5] F. Izzo,et al. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2 , 2016, Oncotarget.
[6] M. Neurath,et al. Advances in hepatitis C therapy: What is the current state - what come's next? , 2016, World journal of hepatology.
[7] D. Serraino,et al. Hepatitis C virus and non-Hodgkin's lymphomas: Meta-analysis of epidemiology data and therapy options. , 2016, World journal of hepatology.
[8] F. Castelli,et al. Chronic HCV infection: epidemiological and clinical relevance , 2012, BMC Infectious Diseases.
[9] D. Sansonno,et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. , 2000, Seminars in liver disease.